Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041).

Source:http://linkedlifedata.com/resource/pubmed/id/20145168

Clin. Cancer Res. 2010 Feb 15 16 4 1315-23

Download in:

View as

Triples

General Info

PMID
20145168